NOT ALL TECHNOLOGY IS CREATED EQUAL

We built more than 50 years of scientific and technical experience into our eCOA environment. Streamlined workflows and regulatory adherence make ERT eCOA easy to use with less burden for both sites and patients.

2600+
eCOA Trials
68
eCOA drug approvals
150K
total sites
1M+
eCOA patients

HAVE CONFIDENCE IN YOUR TRIAL DATA

By implementing ERT’s eCOA solution in your next clinical trial, you will benefit from higher-quality, consistent data that you can have confidence in.

ACHIEVE MAXIMUM QUALITY

Data quality can be compromised by error-prone, manual, paper-based systems. eCOA, however, ensures that all data meets global regulatory quality standards, prevents inconsistent or conflicting data, eliminates transcription errors and avoids study bias with predictable data collection.

Download ‘7 Reasons to Implement Electronic Data Collection’ to learn how ERT’s eCOA helps improve data quality.

REDUCE DATA VARIABILITY BY 40% WHEN USING eCOA

INCREASE DATA CONSISTENCY

Universal screen features and functions facilitate consistent and predictable data collection on a smartphone, tablet or browser. This capability provides more efficient study change management by offering a more comprehensive view of patient data and mitigating the need for data reconciliation.

Download this best practices guide to learn how ERT’s clinician rater training has been shown to improve data consistency.

CUSTOMIZE TRAINING FOR CONSISTENT DATA COLLECTION AND ASSESSMENT

INTEGRATE WITH OTHER DEVICES

With eCOA, you can save time and study costs by avoiding the manual collection of patient data from different sources. eCOA easily integrates with other medical devices, wearables and EDC systems, transmitting data wirelessly and securely to the study database.

Download this case study to learn how Gilead streamlined data management and reduced discrepancies across integrated systems.

IMPROVE DATA QUALITY WITH DEVICE INTEGRATION

REAL-TIME STUDY INSIGHTS & COST SAVINGS

Monitor patient safety and site performance 24/7, while benefiting from operational efficiencies.

MONITOR SAFETY & PERFORMANCE IN REAL-TIME

ERT’s eCOA delivers real-time insights into patient safety, enabling early detection of any potential safety concerns. Study performance can also be monitored 24/7 at the click of a button.

Read this best practices guide to learn how you can monitor patient safety and study performance in real-time.

AUTOMATED ALERTS FLAG ANY SAFETY CONCERNS

REDUCE STUDY COSTS

With eCOA, you can avoid all the hidden costs of paper – including manual data entry, transcription, data cleaning, reconciliation and archiving. Given the data volumes represented by patient diaries, electronic validation alone can save 30 to 50% of trial costs.

Download this case study to learn how ERT helped Celgene save $13M in overall trial costs using eCOA.

SAVE 30-50% OF TRIAL COSTS WITH ELECTRONIC VALIDATION

INCREASE ENGAGEMENT & COMPLIANCE

Diary compliance can reach well over 90% with eCOA, compared to just 11% with paper. eCOA’s email alerts, electronic reminders, motivational messaging and educational content contribute to better patient engagement and protocol compliance.

Enable more standardized outcomes with consistent, quality data

SCIENTIFIC EXPERTISE PAIRED WITH EVERY PROTOCOL

Our eCOA clinical scientists optimize study power by reviewing every protocol, assessment and study design for suitable content and patient compliance.

ENSURE STUDY DESIGN IS FIT-FOR-PURPOSE

Our 25-member team of clinical psychologists, neurologists, psychometricians and COA scientists design assessments and programs with electronic implementation in mind, using a dual layer of PRO and eCOA best practices. Customized rater training for clinicians, caregivers, patients and site staff safeguards the standardized use of each instrument. The team also ensures the trustworthiness of your electronic records through data protection and fraud avoidance.

THE INDUSTRY’S LARGEST, MOST EXPERIENCED RESIDENT PRO & eCOA SCIENCE TEAM

MIGRATE TO ELECTRONIC ASSESSMENTS

Our science team has the experience working with scientific focus groups for usability and the necessary regulatory agencies for approval of new assessments. Team members can conduct cognitive debriefing and testing to ensure the electronic method is collecting the same data and in the same spirit as the paper-based method. Or, they can assist you to create a new standardized assessment, when one isn’t already available.

Read this best practices guide to learn what to consider when selecting eCOA.

EACH INSTRUMENT MUST BE VALIDATED FOR ELECTRONIC IMPLEMENTATION

DEVELOP AND REVIEW ALL PROTOCOLS

Early knowledge of the protocol enables our scientific team to determine what has to be proven and achieved for patient and site compliance. Then, the PRO and eCOA trial design strategies, endpoint selection and instrument selection for optimal study power are determined based on the protocol. The team is also involved when protocol amendments are required.

INCREASE PROTOCOL COMPLIANCE

REDUCE eDIARY CARD DELIVERY TIME BY 75%

Collect fast, regulatory compliant, and cost-effective eCOA data for vaccine studies with our vaccines platform.

STREAMLINE VACCINE STUDY TIMELINES

Vaccine development typically faces more aggressive timelines than traditional clinical trials. With ERT, you can implement a standards-based eCOA solution that enables a rapid, cost-efficient and consistent means to capture high-quality eSource patient data. This provides:

  • Faster eDiary card delivery times
  • Lower vaccine study costs
  • 24/7 visibility to study data

Text

IMPROVE PATIENT DATA QUALITY

Research shows that electronic data capture is preferred over paper data collection by patients and regulators. So why isn’t every vaccine study collecting eSource data?

Download this eBook to learn how the ERT Vaccines Platform helps you overcome common study challenges associated with patient data capture


OVERCOME PAPER-BASED DATA COLLECTION CHALLENGES

EFFICIENT DESIGN

Developing eDiary cards from scratch for every vaccine study wastes time – and money. ERT’s Vaccines Platform provides a reusable set of standards to facilitate electronic data capture and collect more standardized and higher-quality patient data.

Learn how ERT’s Vaccines Platform uses an efficient design to benefit sponsors, sites and patients.


REDUCE BURDEN ON SITES, SPONSORS AND PATIENTS

BUILD CONFIDENCE IN SUICIDE RISK SCREENINGS

Integrate our electronic suicide risk assessments within any study to screen for suicidal ideation and behavior.

ENSURE PROPER SUICIDE IDEATION ASSESSMENTS

Although psychiatric studies are well positioned for trained clinicians to assess suicidal ideation, non-psychiatric studies may involve clinicians who are not familiar or comfortable in assessing suicidal ideation. Both ERT electronic Suicide Risk Assessment versions — clinician-reported and patient-reported — ensure proper screening.

Get all the details on our integrated suicide risk assessments.

PROPERLY ASSESS SUICIDE RISK

POWER ECONOMICAL ASSESSMENTS

Our solution electronically integrates the Columbia-Suicide Severity Rating Scale (C-SSRS), which is the SIB assessment gold standard. The electronic C-SSRS uses a complex, systematic structure of questions that logically branch to the appropriate follow-up questions based on patient responses. The scale directly maps to and populates 11 categories of suicidal ideation and behavior, mitigating potential clinician errors in coding.

Find out more about electronic patient-reported suicidal ideation in eCOA.

REAL TIME SIB ALERTS

REDUCE PATIENT AND SITE BURDEN

Our proprietary, electronic C-SSRS (eC-SSRS) assessment provides systematic, comprehensive and consistent assessments by patient self-report across all sites and languages. It reduces patient and site staff burden and the time to collect the data. Because screening is accelerated, alerts for suicide ideation are more timely.

Learn about the reliability and validity of tablet-based eC-SSRS administration.

INCREASE EFFICIENCY WITH PATIENT-REPORTED SIB

TAKE A CLOSER LOOK

Introducing BYOD 2.0: A More Inclusive Approach to Electronic Clinical Outcome Assessment

Here we present how the next wave of ePRO BYOD leverages new technologies to expand the inclusiveness of research by supporting data collection from verbal computer interfaces and wearable/external devices.

ARTICLE: ELECTRONIC PLATFORMS DRIVE IMPROVEMENTS IN VACCINE STUDY EFFICIENCY AND DATA QUALITY

Read this article to learn how the latest electronic data capture solutions are helping to deliver safe and effective vaccines faster and more cost-effectively.

ADDITIONAL INSIGHTS

INFOGRAPHIC: 4 WAYS TO IMPROVE PATIENT DATA CAPTURE IN VACCINES STUDIES

Find out how a vaccines platform helps meet FPI, shortens time to database lock, reduces site burden and ensures high-quality data.

CASE STUDY: ePRO PRODUCES HIGHER-QUALITY DATA THAN PAPER

Learn how Merck demonstrated a 41% reduction in standard deviation from the norm using ePRO.